NCT03077386Completed
Enhancing Community Health Through Patient Navigation, Advocacy and Social Support
Source: ClinicalTrials.gov · Last updated 23 May 2024
Brief summary (registry, in English)
Some patients who have multiple long-term health conditions have significant challenges accessing needed services despite available primary care and social services resources. Patient navigation programs may help those with complex health conditions improve their care and outcomes and if delivered by community health navigators (CHNs) who have close community ties, these programs have the potential to reduce barriers to care and increase access to coordinated, person-centred care. The ENCOMPASS program aims to improve the care and health outcomes for high-risk patients by linking patients with chronic disease with a CHN to help them navigate the health system, facilitate communication between patients and providers, improve patients' understanding of their conditions and treatment plans, and support patients in their self-management. In Canada, patient navigation programs have not been well studied or broadly implemented in patients with chronic disease, making a comprehensive evaluation of ENCOMPASS important. This program has great potential to improve care for patients with chronic diseases in primary care.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 176 (actual)
- First submitted
- 1 Mar 2017
- Start date
- Jun 2018
- Primary completion date
- Mar 2023
- Lead sponsor
- University of Calgary
- Diseases
- Chronic kidney disease, Heart failure, Coronary artery disease, Asthma, COPD, High blood pressure, Type 2 diabetes
- NCT number
- NCT03077386
What you commit to
- Study type: Interventional
- Participants enrolled: 176
- From Jun 2018 to the primary completion date, Mar 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- patient unable to provide informed consent;
- patient residing in a long-term care facility;
- physician discretion.
Who the study is looking for
- ≥ 18 years of age with two or more of the following:
- Poorly controlled hypertension (most recent systolic blood pressure \> 160 mmHg);
- Poorly controlled diabetes (A1C \> 9% on at least one occasion within the past year);
- Stage 3b or greater chronic kidney disease (estimated glomerular filtration rate \< 45 mL/min/1.73m2 in past year);
- Established ischemic heart disease (at least one instance of a physician billing diagnosis with a relevant International Classification of Diseases, 9th Edition \[ICD-9\] code recorded in electronic medical record (EMR), or known to health care team);
- Congestive heart failure (at least one instance of a physician billing diagnosis with a relevant ICD-9 code recorded in EMR, or known to health care team);
- Chronic obstructive pulmonary disease OR Asthma with at least two visits in the past year (at least 2 instances of a physician billing diagnosis with a relevant ICD-9 code, or known to health care team).
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mosaic Primary Care Network Coordinator of this site? Confirm its status | Calgary | Canada | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.